Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$472M |
| 2 |
Canadian National Railway
CNI
|
+$378M |
| 3 |
Agnico Eagle Mines
AEM
|
+$269M |
| 4 |
Bank of America
BAC
|
+$254M |
| 5 |
Deutsche Bank
DB
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$708M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$364M |
| 3 |
UnitedHealth
UNH
|
+$296M |
| 4 |
Prologis
PLD
|
+$281M |
| 5 |
Newmont
NEM
|
+$254M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Healthcare | 14.72% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 7.71% |
| 5 | Communication Services | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Under Armour Class C
UA
$2.77B
| $64K | ﹤0.01% |
8,393
-390,871
| -98% | -$4.4M |
|
3577
Global X Uranium ETF
URA
$5.42B
| $64K | ﹤0.01% |
3,448
| – | – |
|
|
SNCE
3578
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $64K | ﹤0.01% |
+1,588
| New | +$116K |
|
3579
Aemetis
AMTX
$106M
| $63K | ﹤0.01% |
12,810
-7,570
| -37% | -$66.2K |
|
3580
AudioCodes
AUDC
$244M
| $63K | ﹤0.01% |
2,881
+672
| +30% | +$15.4K |
|
3581
Celestica
CLS
$38.1B
| $63K | ﹤0.01% |
6,462
| – | – |
|
3582
Ginkgo Bioworks
DNA
$528M
| $63K | ﹤0.01% |
+663
| New | +$80.9K |
|
3583
Galicia Financial Group
GGAL
$7.99B
| $63K | ﹤0.01% |
9,089
-9,873
| -52% | -$88.3K |
|
3584
Perion Network
PERI
$375M
| $63K | ﹤0.01% |
3,477
-10,728
| -76% | -$222K |
|
3585
Precigen
PGEN
$2.24B
| $63K | ﹤0.01% |
47,353
-6,519
| -12% | -$9.67K |
|
|
TARO
3586
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $63K | ﹤0.01% |
1,755
+370
| +27% | +$14.1K |
|
|
VIRX
3587
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $62K | ﹤0.01% |
15,882
-3,799
| -19% | -$10.8K |
|
|
FXLV
3588
DELISTED
F45 Training Holdings Inc.
FXLV
| $62K | ﹤0.01% |
15,823
-1,490
| -9% | -$10.9K |
|
3589
Traeger
COOK
$178M
| $61K | ﹤0.01% |
289
-58
| -17% | -$16.2K |
|
3590
Lexicon Pharmaceuticals
LXRX
$1.03B
| $61K | ﹤0.01% |
33,092
-4,803
| -13% | -$9.16K |
|
3591
Nautilus Biotechnolgy
NAUT
$124M
| $61K | ﹤0.01% |
+22,536
| New | +$83.9K |
|
|
IMDX
3592
Insight Molecular Diagnostics
IMDX
$150M
| $61K | ﹤0.01% |
3,384
+824
| +32% | +$18.7K |
|
3593
Arteris
AIP
$1.38B
| $60K | ﹤0.01% |
8,513
+5,768
| +210% | +$59.1K |
|
|
AOMR
3594
Angel Oak Mortgage REIT
AOMR
$220M
| $60K | ﹤0.01% |
4,610
+685
| +17% | +$10.1K |
|
3595
Crawford & Co Class A
CRD.A
$532M
| $60K | ﹤0.01% |
7,705
-1,114
| -13% | -$8.66K |
|
3596
Nature's Sunshine
NATR
$354M
| $60K | ﹤0.01% |
5,623
-822
| -13% | -$11.4K |
|
3597
Outlook Therapeutics
OTLK
$183M
| $60K | ﹤0.01% |
2,914
+329
| +13% | +$9.46K |
|
3598
Pyxis Oncology
PYXS
$168M
| $60K | ﹤0.01% |
25,000
-5,783
| -19% | -$15.4K |
|
3599
iShares Global REIT ETF
REET
$5.09B
| $60K | ﹤0.01% |
2,500
| – | – |
|
|
EXPR
3600
DELISTED
Express, Inc.
EXPR
| $60K | ﹤0.01% |
+1,519
| New | +$91.2K |
|
Similar funds
Deutsche Bank's Q2 2022 Portfolio in Review
As of Q2 2022, Deutsche Bank held 4,489 positions worth $179B, down 16% from $214B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Deutsche Bank's Q2 2022 filing shows 288 new, 1,136 increased, 2,191 reduced and 362 closed positions. Its largest new stake was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 2,000,000 shares worth $65.3M. The largest sale was Microsoft, an estimated $708M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q2 2022 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 2,000,000 shares worth $65.3M.
- Deutsche Bank added most to American Tower in Q2 2022, an estimated $472M increase.
- Deutsche Bank's biggest Q2 2022 reduction was Microsoft, cutting an estimated $708M.
- Deutsche Bank fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Deutsche Bank's ten largest holdings make up 19% of its $179B portfolio in Q2 2022.
- Deutsche Bank opened 288 new positions and closed 362 in Q2 2022.
- Deutsche Bank's portfolio value fell 16% quarter-over-quarter to $179B.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.